Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
November-2019 Volume 20 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2019 Volume 20 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Effects of the transcription factor Olig1 on the differentiation and remyelination of oligodendrocyte precursor cells after focal cerebral ischemia in rats

  • Authors:
    • Hong Zhao
    • Xiao‑Yu Gao
    • Zan‑Hua Liu
    • Jian‑Wen Lin
    • Su‑Ping Wang
    • De‑Xin Wang
    • Yong‑Bo Zhang
  • View Affiliations / Copyright

    Affiliations: Department of Neurology, Dalian Municipal Central Hospital, Dalian, Liaoning 116033, P.R. China, Department of Neurology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, P.R. China, Department of Neurology, Nanjing Gaochun People's Hospital, Nanjing, Jiangsu 211300, P.R. China, Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, P.R. China
    Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 4603-4611
    |
    Published online on: September 26, 2019
       https://doi.org/10.3892/mmr.2019.10713
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The differentiation and maturation of oligodendrocyte precursor cells (OPCs) is important for remyelination in the central nervous system. Nevertheless, this process is often limited and incomplete in ischemic injury. Oligodendrocyte transcription factor 1 (Olig1) is important for the maturation of OPCs and the repair of demyelinated lesions. However, how Olig1 modulates the development of OPCs or the remyelination associated with ischemic injury remains unclear. The present study aimed to examine alterations in OPCs, and the expression of myelin and Olig1, at different time-points after focal cerebral ischemia using immunohistochemistry and western blot techniques to elucidate the role of Olig1 in the maturation of OPCs and remyelination. The present results showed that the expression of Olig1 significantly decreased at 1 day after middle cerebral artery occlusion (MCAO) and returned to normal levels from day 3 to 28. Additionally, Olig1 was found to translocate into the nucleus following ischemia in the brain. The number of OPCs in the ischemic striatum significantly declined at days 1 and 3 following MCAO, and increased at days 7, 14 and 28 compared with the control. The expression of myelin basic protein, a marker of mature oligodendrocytes and myelin, gradually decreased from day 1 to 7 after ischemia and recovered at day 14 and 28; however, the levels were lower than those in the control group. The present results indicated that the restored normal level of Olig1 following ischemia may play an important role in the maturation of OPCs through its translocation into the nucleus, where it may promote the growth and development of myelin under pathological conditions. However, this endogenous recovery mechanism fails to fully repair the demyelinated lesion. The data of the present study may help clinicians understand the expression pattern of Olig1 and its potential role in endogenous remyelination after ischemia, which may have implications for the treatment of diseases that lead to demyelination.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Marin MA and Carmichael ST: Stroke in CNS white matter: Models and mechanisms. Neurosci Lett. 684:193–199. 2018. View Article : Google Scholar : PubMed/NCBI

2 

Goldberg MP and Ransom BR: New light on white matter. Stroke. 34:330–332. 2003. View Article : Google Scholar : PubMed/NCBI

3 

Pantoni L, Garcia JH and Gutierrez JA: Cerebral white matter is highly vulnerable to ischemia. Stroke. 27:1641–1647. 1996. View Article : Google Scholar : PubMed/NCBI

4 

Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, Arvin KL and Holtzman DM: Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci. 22:455–463. 2002. View Article : Google Scholar : PubMed/NCBI

5 

Dewar D, Underhill SM and Goldberg MP: Oligodendrocytes and ischemic brain injury. J Cereb Blood Flow Metab. 23:263–274. 2003. View Article : Google Scholar : PubMed/NCBI

6 

Nishiyama A: Polydendrocytes: NG2 cells with many roles in development and repair of the CNS. Neuroscientist. 13:62–76. 2007. View Article : Google Scholar : PubMed/NCBI

7 

Dawson MR, Polito A, Levine JM and Reynolds R: NG2-expressing glial progenitor cells: An abundant and widespread population of cycling cells in the adult rat CNS. Mol Cell Neurosci. 24:476–488. 2003. View Article : Google Scholar : PubMed/NCBI

8 

Eugenín-von Bernhardi J and Dimou L: NG2-glia, more than progenitor cells. Adv Exp Med Biol. 949:27–45. 2016. View Article : Google Scholar : PubMed/NCBI

9 

van Tilborg E, de Theije CGM, van Hal M, Wagenaar N, de Vries LS, Benders MJ, Rowitch DH and Nijboer CH: Origin and dynamics of oligodendrocytes in the developing brain: Implications for perinatal white matter injury. Glia. 66:221–238. 2018. View Article : Google Scholar : PubMed/NCBI

10 

Keirstead HS and Blakemore WF: The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination. Adv Exp Med Biol. 468:183–197. 1999. View Article : Google Scholar : PubMed/NCBI

11 

Nishiyama A, Komitova M, Suzuki R and Zhu X: Polydendrocytes (NG2 cells): Multifunctional cells with lineage plasticity. Nat Rev Neurosci. 10:9–22. 2009. View Article : Google Scholar : PubMed/NCBI

12 

Tanaka K, Nogawa S, Suzuki S, Dembo T and Kosakai A: Upregulation of oligodendrocyte progenitor cells associated with restoration of mature oligodendrocytes and myelination in peri-infarct area in the rat brain. Brain Res. 989:172–179. 2003. View Article : Google Scholar : PubMed/NCBI

13 

Franklin RJ: Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci. 3:705–714. 2002. View Article : Google Scholar : PubMed/NCBI

14 

Lubetzki C, Williams A and Stankoff B: Promoting repair in multiple sclerosis: Problems and prospects. Curr Opin Neurol. 18:237–244. 2005. View Article : Google Scholar : PubMed/NCBI

15 

Ross SE, Greenberg ME and Stiles CD: Basic helix-loop-helix factors in cortical development. Neuron. 39:13–25. 2003. View Article : Google Scholar : PubMed/NCBI

16 

Zhou Q, Wang S and Anderson DJ: Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron. 25:331–343. 2000. View Article : Google Scholar : PubMed/NCBI

17 

Miller RH: Regulation of oligodendrocyte development in the vertebrate CNS. Prog Neurobiol. 67:451–467. 2002. View Article : Google Scholar : PubMed/NCBI

18 

Jakovcevski I and Zecevic N: Olig transcription factors are expressed in oligodendrocyte and neuronal cells in human fetal CNS. J Neurosci. 25:10064–10073. 2005. View Article : Google Scholar : PubMed/NCBI

19 

Zhou Q and Anderson DJ: The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell. 109:61–73. 2002. View Article : Google Scholar : PubMed/NCBI

20 

Lu QR, Sun T, Zhu Z, Ma N, Garcia M, Stiles CD and Rowitch DH: Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell. 109:75–86. 2002. View Article : Google Scholar : PubMed/NCBI

21 

Takebayashi H and Nabeshima Y, Yoshida S, Chisaka O, Ikenaka K and Nabeshima Y: The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages. Curr Biol. 12:1157–1163. 2002. View Article : Google Scholar : PubMed/NCBI

22 

Arnett HA, Fancy SP, Alberta JA, Zhao C, Plant SR, Kaing S, Raine CS, Rowitch DH, Franklin RJ and Stiles CD: bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science. 306:2111–2115. 2004. View Article : Google Scholar : PubMed/NCBI

23 

Dai J, Bercury KK, Jin W and Macklin WB: Olig1 Acetylation and nuclear export mediate oligodendrocyte development. J Neurosci. 35:15875–15893. 2015. View Article : Google Scholar : PubMed/NCBI

24 

Niu J, Mei F, Wang L, Liu S, Tian Y, Mo W, Li H, Lu QR and Xiao L: Phosphorylated olig1 localizes to the cytosol of oligodendrocytes and promotes membrane expansion and maturation. Glia. 60:1427–1436. 2012. View Article : Google Scholar : PubMed/NCBI

25 

Tonchev AB, Yamashima T, Sawamoto K and Okano H: Transcription factor protein expression patterns by neural or neuronal progenitor cells of adult monkey subventricular zone. Neuroscience. 139:1355–1367. 2006. View Article : Google Scholar : PubMed/NCBI

26 

Longa EZ, Weinstein PR, Carlson S and Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:84–91. 1989. View Article : Google Scholar : PubMed/NCBI

27 

Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL and Bartkowski H: Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination. Stroke. 17:472–476. 1986. View Article : Google Scholar : PubMed/NCBI

28 

Tu H, Deng L, Sun Q, Yao L, Han JS and Wan Y: Hyperpolarization-activated, cyclic nucleotide-gated cation channels: Roles in the differentialelectrophysiological properties of rat primary afferent neurons. J Neurosci Res. 76:713–722. 2004. View Article : Google Scholar : PubMed/NCBI

29 

Luo H, Cheng J, Han JS and Wan Y: Change of vanilloid receptor 1 expression in dorsal root ganglion and spinal dorsal horn during inflammatory nociception induced by complete Freund's adjuvant in rats. Neuroreport. 15:655–658. 2004. View Article : Google Scholar : PubMed/NCBI

30 

Jiang YQ, Xing GG, Wang SL, Tu HY, Chi YN, Li J, Liu FY, Han JS and Wan Y: Axonal accumulation of hyperpolarization-activated cyclic nucleotide-gated cation channels contributes to mechanical allodynia after peripheral nerve injury in rat. Pain. 137:495–506. 2008. View Article : Google Scholar : PubMed/NCBI

31 

Song FE, Huang JL, Lin SH, Wang S, Ma GF and Tong XP: Roles of NG2-glia in ischemic stroke. CNS Neurosci Ther. 23:547–553. 2017. View Article : Google Scholar : PubMed/NCBI

32 

Mandai K, Matsumoto M, Kitagawa K, Matsushita K, Ohtsuki T, Mabuchi T, Colman DR, Kamada T and Yanagihara T: Ischemic damage and subsequent proliferation of oligodendrocytes in focal cerebral ischemia. Neuroscience. 77:849–861. 1997. View Article : Google Scholar : PubMed/NCBI

33 

Chamberlain KA, Nanescu SE, Psachoulia K and Huang JK: Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis. Neuropharmacology. 110:633–643. 2016. View Article : Google Scholar : PubMed/NCBI

34 

Bu J, Banki A, Wu Q and Nishiyama A: Increased NG2(+) glial cell proliferation and oligodendrocyte generation in the hypomyelinating mutant shiverer. Glia. 4:51–63. 2004. View Article : Google Scholar

35 

Luessi F, Kuhlmann T and Zipp F: Remyelinating strategies in multiple sclerosis. Expert Rev Neurother. 14:1315–1334. 2014. View Article : Google Scholar : PubMed/NCBI

36 

Paes de Faria J, Kessaris N, Andrew P, Richardson WD and Li H: New Olig1 null mice confirm a non-essential role for Olig1 in oligodendrocyte development. BMC Neurosci. 15:122014. View Article : Google Scholar : PubMed/NCBI

37 

Qi Q, Zhang Y, Shen L, Wang R, Zhou J, Lü H and Hu J: Olig1 expression pattern in neural cells during rat spinal cord development. Neuropsychiatr Dis Treat. 12:909–916. 2016.PubMed/NCBI

38 

Sabo JK, Heine V, Silbereis JC, Schirmer L, Levison SW and Rowitch DH: Olig1 is required for noggin-induced neonatal myelin repair. Ann Neurol. 81:560–571. 2017. View Article : Google Scholar : PubMed/NCBI

39 

Lu QR, Yuk D, Alberta JA, Zhu Z, Pawlitzky I, Chan J, McMahon AP, Stiles CD and Rowitch DH: Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron. 25:317–329. 2000. View Article : Google Scholar : PubMed/NCBI

40 

Ligon KL, Kesari S, Kitada M, Sun T, Arnett HA, Alberta JA, Anderson DJ, Stiles CD and Rowitch DH: Development of NG2 neural progenitor cells requires Olig gene function. Proc Natl Acad Sci USA. 103:7853–7858. 2006. View Article : Google Scholar : PubMed/NCBI

41 

Dawson MR, Levine JM and Reynolds R: NG2-expressing cells in the central nervous system: Are they oligodendroglial progenitors? J Neurosci Res. 61:471–479. 2000. View Article : Google Scholar : PubMed/NCBI

42 

Peters A and Sethares C: Is there remyelination during aging of the primate central nervous system? J Comp Neurol. 460:238–254. 2003. View Article : Google Scholar : PubMed/NCBI

43 

Franklin RJ, Zhao C and Sim FJ: Ageing and CNS remyelination. Neuroreport. 13:923–928. 2002. View Article : Google Scholar : PubMed/NCBI

44 

Cheng T, Xue X and Fu J: Effect of Olig1 on the development of oligodendrocytes and myelination in a neonatal rat PVL model induced by hypoxia-ischemia. Mol Med Rep. 11:2379–2386. 2015. View Article : Google Scholar : PubMed/NCBI

45 

Zhao H, Gao XY, Wang DX and Zhang YB: Effect of adenovirus-mediated gene transfer of Olig1 on oligodendrocyte differentiation and remyelination in a rat model of focal cerebral ischemia. Neural Regen Res. 4:862–867. 2009.

46 

He L and Lu QR: Coordinated control of oligodendrocyte development by extrinsic and intrinsic signaling cues. Neurosci Bull. 29:129–143. 2013. View Article : Google Scholar : PubMed/NCBI

47 

Fancy SP, Zhao C and Franklin RJ: Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol Cell Neurosci. 27:247–254. 2004. View Article : Google Scholar : PubMed/NCBI

48 

Balasubramaniyan V, Timmer N, Kust B, Boddeke E and Copray S: Transient expression of Olig1 initiates the differentiation of neural stem cells into oligodendrocyte progenitor cells. Stem Cells. 22:878–882. 2004. View Article : Google Scholar : PubMed/NCBI

49 

Watanabe M, Hadzic T and Nishiyama A: Transient upregulation of Nkx2.2 expression in oligodendrocyte lineage cells during remyelination. Glia. 46:311–322. 2004. View Article : Google Scholar : PubMed/NCBI

50 

Soundarapandian MM, Selvaraj V, Lo UG, Golub MS, Feldman DH, Pleasure DE and Deng W: Zfp488 promotes oligodendrocyte differentiation of neural progenitor cells in adult mice after demyelination. Sci Rep. 1:22011. View Article : Google Scholar : PubMed/NCBI

51 

Finzsch M, Stolt CC, Lommes P and Wegner M: Sox9 and Sox10 influence survival and migration of oligodendrocyte precursors in the spinal cord by regulating PDGF receptor alpha expression. Development. 135:637–646. 2008. View Article : Google Scholar : PubMed/NCBI

52 

Talbott JF, Loy DN, Liu Y, Qiu MS, Bunge MB, Rao MS and Whittemore SR: Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes. Exp Neurol. 192:11–24. 2005. View Article : Google Scholar : PubMed/NCBI

53 

Carmen J, Magnus T, Cassiani-Ingoni R, Sherman L, Rao MS and Mattson MP: Revisiting the astrocyte-oligodendrocyte relationship in the adult CNS. Prog Neurobiol. 82:151–162. 2007. View Article : Google Scholar : PubMed/NCBI

54 

Haindl MT, Köck U, Zeitelhofer-Adzemovic M, Fazekas F and Hochmeister S: The formation of a glial scar does not prohibit remyelination in an animal model of multiple sclerosis. Glia. 67:467–481. 2019. View Article : Google Scholar : PubMed/NCBI

55 

Williams A, Piaton G and Lubetzki C: Astrocytes-friends or foes in multiple sclerosis? Glia. 55:1300–1312. 2007. View Article : Google Scholar : PubMed/NCBI

56 

Kotter MR, Li WW, Zhao C and Franklin RJ: Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci. 26:328–332. 2006. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhao H, Gao XY, Liu ZH, Lin JW, Wang SP, Wang DX and Zhang YB: Effects of the transcription factor Olig1 on the differentiation and remyelination of oligodendrocyte precursor cells after focal cerebral ischemia in rats. Mol Med Rep 20: 4603-4611, 2019.
APA
Zhao, H., Gao, X., Liu, Z., Lin, J., Wang, S., Wang, D., & Zhang, Y. (2019). Effects of the transcription factor Olig1 on the differentiation and remyelination of oligodendrocyte precursor cells after focal cerebral ischemia in rats. Molecular Medicine Reports, 20, 4603-4611. https://doi.org/10.3892/mmr.2019.10713
MLA
Zhao, H., Gao, X., Liu, Z., Lin, J., Wang, S., Wang, D., Zhang, Y."Effects of the transcription factor Olig1 on the differentiation and remyelination of oligodendrocyte precursor cells after focal cerebral ischemia in rats". Molecular Medicine Reports 20.5 (2019): 4603-4611.
Chicago
Zhao, H., Gao, X., Liu, Z., Lin, J., Wang, S., Wang, D., Zhang, Y."Effects of the transcription factor Olig1 on the differentiation and remyelination of oligodendrocyte precursor cells after focal cerebral ischemia in rats". Molecular Medicine Reports 20, no. 5 (2019): 4603-4611. https://doi.org/10.3892/mmr.2019.10713
Copy and paste a formatted citation
x
Spandidos Publications style
Zhao H, Gao XY, Liu ZH, Lin JW, Wang SP, Wang DX and Zhang YB: Effects of the transcription factor Olig1 on the differentiation and remyelination of oligodendrocyte precursor cells after focal cerebral ischemia in rats. Mol Med Rep 20: 4603-4611, 2019.
APA
Zhao, H., Gao, X., Liu, Z., Lin, J., Wang, S., Wang, D., & Zhang, Y. (2019). Effects of the transcription factor Olig1 on the differentiation and remyelination of oligodendrocyte precursor cells after focal cerebral ischemia in rats. Molecular Medicine Reports, 20, 4603-4611. https://doi.org/10.3892/mmr.2019.10713
MLA
Zhao, H., Gao, X., Liu, Z., Lin, J., Wang, S., Wang, D., Zhang, Y."Effects of the transcription factor Olig1 on the differentiation and remyelination of oligodendrocyte precursor cells after focal cerebral ischemia in rats". Molecular Medicine Reports 20.5 (2019): 4603-4611.
Chicago
Zhao, H., Gao, X., Liu, Z., Lin, J., Wang, S., Wang, D., Zhang, Y."Effects of the transcription factor Olig1 on the differentiation and remyelination of oligodendrocyte precursor cells after focal cerebral ischemia in rats". Molecular Medicine Reports 20, no. 5 (2019): 4603-4611. https://doi.org/10.3892/mmr.2019.10713
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team